26
Nov
2024

GENEXT GENOMICS PVT LTD

Exhibitor at CPHI & PMEC India 2024 stand SP2
About Us

Genext Genomics Pvt Ltd is a life science research Company and contract research organization in central India, with focus on providing purpose-based solution for life science customers. We specialize in large scale expression and purification of native as well as recombinant proteins from virtually any source! Major thrust area are diagnostic and therapeutic protein development. We also specialize in developing biosimilar cell lines and process know-how. 

  • IN
  • 2024
    On CPHI since
  • 1
    Certificates
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Contact info
  • 03, Abhyankar Nagar, near Zenda Chowk,, Nagpur, India
Event information
CPHI & PMEC India 2024
  • 26 Nov 2024 - 28 Nov 2024
  • India Expo Centre, Greater Noida, Delhi NCR
  • Visit us at stand SP2

Products Featured at CPHI & PMEC India 2024

  • Biosimilar Clone Development Service

    Product Biosimilar Clone Development Service

    At GeNext Genomics, we specialize in end-to-end clone development for biosimilars, catering to the high demand for biologics. Utilizing advanced cell lines such as CHO GS, Expi CHO, HEK, and CHO S, we ensure high-yield, high-quality biosimilar production. Our approach includes detailed characterization and...
  • Golimumab

    Product Golimumab

    Golimumab is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a cytokine involved in inflammatory responses. By blocking TNF-α, golimumab helps reduce inflammation and is primarily used to treat autoimmune diseases such as:

    • Rheumatoid arthritis (RA) • Psor...